Fundraising Fox

Nuclivision

Ghent, BE · Founded 2022 · 19 employees on LinkedIn · 2 known investors

Find your way into Nuclivision

Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.

AI & Machine LearningHealthtechMedical Devices

Founders & leadership

Nuclivision was founded in 2022 by Maarten Larmuseau, Tomas Brants, and Simon DeKeyser.

ML
Maarten LarmuseauinCofounder & CEO
TBTomas Brants
Tomas BrantsinCofounder & COO
SDSimon DeKeyser
Simon DeKeyserinCofounder & CTO

Investors · 2

Heran PartnersAntwerp
imec.istartreportedGhent

Funding

SEC filings, press & company announcements

$5.5M disclosed across 1 round · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Ghent start-up Nuclivision uses AI-driven imaging to make PET scans saferbelganewsagency.eu · Jul 2025Nuclivision Raises €5M to Scale AI PET Imagingallaboutai.com · Apr 2025Belgium’s Nuclivision raises €5M for ML-powered PET imaging - Tech.eutech.eu · Apr 2025Nuclivision' nuclear medicine AI platform raises Luminaires funding - Tech.eutech.eu · Feb 2023

Frequently asked questions

What does Nuclivision do?
Nuclivision develops AI software to enhance nuclear medicine imaging, enabling PET centers to increase capacity and reduce costs without replacing equipment. The platform serves clinical departments across Europe and the US.
Who founded Nuclivision?
Nuclivision was founded by Maarten Larmuseau, Tomas Brants, Simon DeKeyser in 2022.
Who are Nuclivision's investors?
Nuclivision's investors include Heran Partners, imec.istart.
How much funding has Nuclivision raised?
Nuclivision has disclosed $5.5M raised across 1 round.
Where is Nuclivision headquartered?
Nuclivision is headquartered in Ghent, BE.